Medix Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	4,256	4,161	4,179	4,273	14,392
Revenue Growth (YoY)	2.28%	-0.43%	-2.20%	-70.31%	20.14%
Cost of Revenue	555	434	442	581	11,102
Gross Profit	3,701	3,727	3,737	3,692	3,290
Selling, General & Admin	3,042	2,878	2,936	2,907	-
Other Operating Expenses	-	-	-	-	2,719
Operating Expenses	3,042	2,925	2,936	2,907	2,791
Operating Income	659	802	801	785	498.99
Interest Expense	-8	-2	-3	-4	-4.4
Interest & Investment Income	13	2	-	24	-
Other Non Operating Income (Expenses)	-3	149	4	17	-42.35
EBT Excluding Unusual Items	661	951	802	822	452.23
Gain (Loss) on Sale of Investments	-	-	-	-9	-
Asset Writedown	-	-	-1	-	-
Other Unusual Items	-	-	-15	-178	-
Pretax Income	661	951	786	635	452.23
Income Tax Expense	227	148	297	234	317.92
Earnings From Continuing Operations	434	803	489	401	134.32
Net Income to Company	434	803	489	401	-
Minority Interest in Earnings	2	-	-	-	-
Net Income	436	803	489	401	134.32
Net Income to Common	436	803	489	401	134.32
Net Income Growth	-45.70%	64.21%	21.95%	198.54%	-
Shares Outstanding (Basic)	8	8	8	8	-
Shares Outstanding (Diluted)	8	8	8	8	-
Shares Change (YoY)	0.87%	3.63%	-0.48%	-	-
EPS (Basic)	56.04	106.41	64.82	52.90	-
EPS (Diluted)	55.29	102.72	64.82	52.90	-
EPS Growth	-46.17%	58.46%	22.53%	-	-
Free Cash Flow	216	485	-	-	-
Free Cash Flow Per Share	27.39	62.04	-	-	-
Gross Margin	86.96%	89.57%	89.42%	86.40%	22.86%
Operating Margin	15.48%	19.27%	19.17%	18.37%	3.47%
Profit Margin	10.24%	19.30%	11.70%	9.38%	0.93%
Free Cash Flow Margin	5.08%	11.66%	-	-	-
EBITDA	720	847	-	-	571.19
EBITDA Margin	16.92%	20.36%	-	-	3.97%
D&A For EBITDA	61	45	-	-	-
EBIT	659	802	801	785	498.99
EBIT Margin	15.48%	19.27%	19.17%	18.37%	3.47%
Effective Tax Rate	34.34%	15.56%	37.79%	36.85%	-